Pancreatic Cancer Research

ResearcherNingxia Medical University General HospitalNo recent work listed

Weijie Yao

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-6884-8903; OpenAlex author ID A5101264814. Sources: OpenAlex.

Their work

Papers
2
Trials
0
Grants
0
Labs led
0
Collaborators
5
Papers, trials and grants by year

2021: 1 paper · 2022: none · 2023: 1 paper

Papers 2

  1. PABPC1 promotes cell proliferation and metastasis in pancreatic adenocarcinoma by regulating COL12A1 expression. Co-author DOI 10.1002/iid3.919↗
  2. miR‑32‑5p suppresses the proliferation and migration of pancreatic adenocarcinoma cells by targeting TLDC1. Co-author DOI 10.3892/mmr.2021.12392↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Zuozheng Wang · 2 shared papers, 2021–2023 · strength 0.33
  2. Guozhong Zhao · 1 shared paper, 2021 · strength 0.12
  3. Yongfeng Hui · 1 shared paper, 2021 · strength 0.12
  4. Peng Yuan · 1 shared paper, 2021 · strength 0.12
  5. Bendong Chen · 1 shared paper, 2021 · strength 0.12

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.